Search for Clinical Trial Results

Sponsored By

Lymphoma, Large-Cell, Immunoblastic - 25 Studies Found

Status Study
Completed Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-10-08
    Interventions:
    • Drug: busulfan Given IV

Completed Study Name: A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Myeloid Leukemia With Multilineage Dysp
    Date: 2006-06-22
    Interventions:
    • Drug: cyclophosphamide Given I
Active, not recruiting Study Name: Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2004-08-04
    Interventions:
    • Drug: fludarabine phosphate Gi
Active, not recruiting Study Name: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2004-03-08
    Interventions:
    • Drug: fludarabine phosphate Gi
Recruiting Study Name: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-13
    Interventions:
    • Other: questionnaire administration

Active, not recruiting Study Name: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Myeloid Leukemia With Multilineage Dysp
    Date: 2009-03-04
    Interventions:
    • Drug: fludarabine phosphate Gi
Active, not recruiting Study Name: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • B-cell Chronic Lymphocytic Leukemia
  • Date: 2014-01-14
    Interventions:
    • Drug: bortezomib Given IV
Active, not recruiting Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
Condition:
  • Adult Grade III Lymphomatoid Granulomatosis
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-27
    Interventions:
    • Drug: brentuximab vedotin Give
Completed Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Myeloid Leukemia in Remission Date: 2013-02-07
    Interventions:
    • Drug: vorinostat Given PO
Completed Study Name: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Condition:
  • Acute Undifferentiated Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Date: 2011-01-07
    Interventions:
    • Drug: deferasirox Given orally
<<< Previous | Next >>>